Center for Advancement of Blood Cancer Therapies

Research

In the Center for Advancement of Blood Cancer Therapies, we emphasize research that uses human models of normal and malignant hematopoiesis: primary human cells, ex vivo 2D and 3D cultures, patient-derived xenografts, bone marrow organoids and human pluripotent stem cells (hPSCs, including induced pluripotent stem cells, iPSCs and embryonic stem cells, ESCs). 

Major Research Areas: